Trials / Completed
CompletedNCT02766855
Efficacy of Topical Cysteamine in Nephropathic Cyctinosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- The Eye Center and The Eye Foundation for Research in Ophthalmology · Academic / Other
- Sex
- All
- Age
- 8 Months – 19 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy of topical cysteamine eye drops in the treatment of corneal cystine crystals deposits in patients with nephropathic cystinosis.
Detailed description
A total of 26 patients with nephropathic cystinosis were included in this prospective study. Patients were evaluated for improvement of corneal cysteine deposits crystals and photophobia following treatment with topical 0.55% cysteamine eye drops.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cysteamine | Patients were asked to use topical cysteamine 0.55% eye drops every 2 hours while awake to both eyes. |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2012-12-01
- Completion
- 2016-03-01
- First posted
- 2016-05-10
- Last updated
- 2016-05-10
Source: ClinicalTrials.gov record NCT02766855. Inclusion in this directory is not an endorsement.